Femke Heindryckx

14PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyFood properties (incl. characteristics and health benefits)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 19, 2026
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.

|Apr 22, 2026
Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

|Feb 10, 2025
Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients.

Nathalie Arendt, Maria Kopsida, Jaafar Khaled

|Jun 14, 2024
Endoplasmic reticulum stress in the pathogenesis of chemotherapy-induced mucositis: Physiological mechanisms and therapeutic implications.

Femke Heindryckx, Markus Sjöblom

|Oct 22, 2022
The progression of doxorubicin-induced intestinal mucositis in rats.

F Kullenberg, K Peters, C Luna-Marco

|Sep 23, 2022
Orthogonality in Principal Component Analysis Allows the Discovery of Lipids in the Jejunum That Are Independent of Ad Libitum Feeding.

David Balgoma, Fredrik Kullenberg, Karsten Peters

Pageof 3

Frequent Collaborators

5 joint publications

Hans Lennernäs

4 joint publications

Fredrik Kullenberg

3 joint publications

Mikael Hedeland

2 joint publications

Karsten Peters